do you have to stay on semaglutide for life Zepbound vs. vs. Wegovy: What's the Difference? How long do you stay

Understanding how tirzepatide compares to other GLP-1 medications requires looking beyond the headline statistics

To help navigate this shifting environment, pharma companies should consider the following imperatives: GLP1s are expanding far beyond diabetes and obesity

Bodies don't want to make their own hormones when receiving them externally

Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N et al (2012) Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists

Many people regain some percentage of the weight after stopping unless strong nutrition and lifestyle habits are already in place